Metastatic adenocarcinoma consistent with primary breast cancer was diagnosed through atypical lingula resection (HR+, HER2 IHC 1+, ISH-negative according to 2018 ASCO/CAP guidelines).The treatment history prior to initiation of trastuzumab deruxtecan is summarized in Table 1. Here, ERBB2 is linked to breast carcinoma.